Peggy Scherle

PRLD

Peggy Scherle serves as Chief Scientific Officer at Prelude Therapeutics Incorporated (PRLD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$2.26M

Net Position

Net Seller

$2.26M

Companies Traded

PRLD

Active Period

Apr 2021 – Aug 2021

6 total trades

Most Recent

Sell PRLD

Aug 30, 2021 · $275.8K

Peggy Scherle's Insider Trading at Prelude Therapeutics Incorporated (PRLD)

Buys

0 · $0.00

Sells

6 · $2.26M

Total Shares Bought

Total Shares Sold

60,000

PRLD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 30, 2021	Sell	7,714	$35.75	$275.8K	176,234
Aug 17, 2021	Sell	2,286	$35.07	$80.2K	172,920
Jul 29, 2021	Sell	20,000	$35.47	$709.4K	173,600
May 11, 2021	Sell	10,000	$40.82	$408.2K	178,956
Apr 15, 2021	Sell	4,630	$38.34	$177.5K	176,133
Apr 9, 2021	Sell	15,370	$39.31	$604.1K	180,001